Tag Archives: Part D

The Rx Industry, PBMs, and Obamacare

By Tom Norton A significant, though as yet not fully understood player in the launch of Obamacare is the pharmacy benefit manager (PBM) industry.  This uncertainty, due in part to the current Obamacare IT chaos, has more than a few Rx leaders worrying about how the PBMs tied to insurers in the program will end […]
Posted in Guest Blog, healthcare, Op-Ed | Also tagged , , , , , , , | 2 Comments

Part D Politics: Medicare Drug Rebates or Price Controls?

Jill Wechsler Blog – PE Feb. 22, 2013 Part D Politics:  Medicare drug rebates or price controls? While health care was barely mentioned in the recent State of the Union address, President Obama generated some interest in his proposal to cut Medicare spending by reducing “taxpayer subsidies to prescription drug companies.” That’s code for requiring […]
Posted in healthcare, Op-Ed, pricing, Regulatory | Also tagged , , , | Leave a comment
  • Categories

  • Meta